— Know what they know.
Not Investment Advice
Also trades as: PHGE-UN (AMEX) · $vol 0M · PHGE-WT (AMEX)

PHGE AMEX

BiomX Inc.
1W: -1.3% 1M: -50.0% 3M: -82.2% YTD: -90.8% 1Y: -97.6% 3Y: -99.8% 5Y: -100.0%
$0.18
-0.01 (-7.09%)
 
Weekly Expected Move ±11.3%
$0 $0 $0 $0 $0
AMEX · Industrials · Aerospace & Defense · Alpha Radar Sell · Power 28 · $292260 mcap · 818855 float · 998.08% daily turnover · Short 50% of daily vol
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$0.3M
52W Range0.1695-13.699
Volume981,508
Avg Volume8,172,863
Beta1.31
Dividend
Analyst Ratings
4 Buy 1 Hold 0 Sell
Consensus Buy
Company Info
CEOMichael Oster
Employees20
SectorIndustrials
IndustryAerospace & Defense
IPO Date2019-03-13
Websitebiomx.com
850 New Burton Road
Dover, DE 19904
US
972 7 2394 2377
About BiomX Inc.

Operating as a holding company, BiomX Inc. is dedicated to advancing technologies within the realms of defense, security, and essential infrastructure. Its diverse array of offerings features specialized solutions like counter-unmanned aerial vehicle systems, intelligent AI-powered command-and-control, comprehensive border and perimeter protection, expansive surveillance capabilities, and aerial fire suppression tools. The firm caters to a broad spectrum of clients, encompassing national defense organizations, primary government contractors, transportation management entities, local municipalities, and key infrastructure operators. BiomX Inc. commenced operations in 2015 and maintains its principal office in Dover, Delaware.

Recent Insider Trades

NameTypeSharesPriceDate
Yeganeh Reuven C-Conversion 530,000 $2.00 2026-03-17
Yeganeh Reuven C-Conversion 1,060 $2.00 2026-03-17
Yeganeh Reuven S-Sale 530,000 $5.00 2026-03-17
Yeganeh Reuven S-Sale 1,300,000 $1.00 2026-03-16
Yeganeh Reuven S-Sale 2,000,000 $1.00 2026-03-16

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms